Xvivo Perfusion AB Statistics
Total Valuation
XVIPY has a market cap or net worth of 1.03 billion. The enterprise value is 1.00 billion.
| Market Cap | 1.03B |
| Enterprise Value | 1.00B |
Important Dates
The last earnings date was Thursday, April 24, 2025.
| Earnings Date | Apr 24, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +4.40% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 25.00M |
Valuation Ratios
The trailing PE ratio is 75.62 and the forward PE ratio is 60.57.
| PE Ratio | 75.62 |
| Forward PE | 60.57 |
| PS Ratio | 12.12 |
| PB Ratio | 4.95 |
| P/TBV Ratio | 7.34 |
| P/FCF Ratio | 440.49 |
| P/OCF Ratio | 109.68 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 74.30, with an EV/FCF ratio of 428.01.
| EV / Earnings | 73.47 |
| EV / Sales | 11.49 |
| EV / EBITDA | 74.30 |
| EV / EBIT | 101.31 |
| EV / FCF | 428.01 |
Financial Position
The company has a current ratio of 5.20, with a Debt / Equity ratio of 0.01.
| Current Ratio | 5.20 |
| Quick Ratio | 3.58 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.22 |
| Debt / FCF | 1.25 |
| Interest Coverage | 2.32 |
Financial Efficiency
Return on equity (ROE) is 6.69% and return on invested capital (ROIC) is 2.92%.
| Return on Equity (ROE) | 6.69% |
| Return on Assets (ROA) | 2.66% |
| Return on Invested Capital (ROIC) | 2.92% |
| Return on Capital Employed (ROCE) | 4.50% |
| Revenue Per Employee | 441,327 |
| Profits Per Employee | 70,716 |
| Employee Count | 190 |
| Asset Turnover | 0.38 |
| Inventory Turnover | 1.13 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +56.08% in the last 52 weeks. The beta is 2.13, so XVIPY's price volatility has been higher than the market average.
| Beta (5Y) | 2.13 |
| 52-Week Price Change | +56.08% |
| 50-Day Moving Average | 9.94 |
| 200-Day Moving Average | 11.05 |
| Relative Strength Index (RSI) | 36.69 |
| Average Volume (20 Days) | 124 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, XVIPY had revenue of 85.18 million and earned 13.65 million in profits. Earnings per share was 0.43.
| Revenue | 85.18M |
| Gross Profit | 63.93M |
| Operating Income | 9.66M |
| Pretax Income | 15.53M |
| Net Income | 13.65M |
| EBITDA | 11.98M |
| EBIT | 9.66M |
| Earnings Per Share (EPS) | 0.43 |
Balance Sheet
The company has 31.47 million in cash and 2.92 million in debt, giving a net cash position of 28.55 million.
| Cash & Cash Equivalents | 31.47M |
| Total Debt | 2.92M |
| Net Cash | 28.55M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 208.45M |
| Book Value Per Share | 6.62 |
| Working Capital | 58.46M |
Cash Flow
In the last 12 months, operating cash flow was 9.41 million and capital expenditures -7.07 million, giving a free cash flow of 2.34 million.
| Operating Cash Flow | 9.41M |
| Capital Expenditures | -7.07M |
| Free Cash Flow | 2.34M |
| FCF Per Share | n/a |
Margins
Gross margin is 75.05%, with operating and profit margins of 11.34% and 16.02%.
| Gross Margin | 75.05% |
| Operating Margin | 11.34% |
| Pretax Margin | 18.23% |
| Profit Margin | 16.02% |
| EBITDA Margin | 14.06% |
| EBIT Margin | 11.34% |
| FCF Margin | 2.75% |
Dividends & Yields
XVIPY does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.40% |
| Shareholder Yield | -4.40% |
| Earnings Yield | 1.32% |
| FCF Yield | 0.23% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
XVIPY has an Altman Z-Score of 42.73.
| Altman Z-Score | 42.73 |
| Piotroski F-Score | n/a |